Generic Clearance for Methodological Studies in the Population Assessment of Tobacco and Health (PATH) Study (NIDA)

This is a reinstatement without change (of OMB number 0925-06764, expiration date 5/31/2016) for the Population Assessment of Tobacco and Health (PATH) Study to conduct methodological substudies to improve its methods for data and biospecimen collection. The PATH Study is collecting behavioral data and biospecimens among a national longitudinal cohort to assess within-person changes and between-person differences in tobacco-product use behaviors and related health conditions over time. Its longitudinal, population-based data will help to enhance the evidence base that informs FDA’s regulatory actions under the Family Smoking Prevention and Tobacco Control Act (TCA) to protect the Nation’s public health and reduce its burden of tobacco-related morbidity and mortality.

The latest form for Generic Clearance for Methodological Studies in the Population Assessment of Tobacco and Health (PATH) Study (NIDA) expires 2021-01-31 and can be found here.